SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCapai Regulatory News (CPAI)

Share Price Information for Capai (CPAI)

Share Price is delayed by 15 minutes
Get Live Data
0.604    -0.015 (-2.22%)
Bid:
0.62
Ask:
0.70
Spread: 0.08 (12.903%)
Market Cap: £2.58m
CPAI Live PriceLast checked at - London Stock Exchange

Intraday Capai Share Chart

PDMR Notifications; Conversion CLNs & Fee Shares

7 Apr 2025 10:04

RNS Number : 9141D
Capai PLC
07 April 2025
 

7 April 2025

 

capAI plc

(the "Company")

 

PDMR Notifications; Conversion of all outstanding CLNs and issue of CLN Shares and Fee Shares

 

 

PDMR Notifications

 

Further to the Company's announcement on 12 March 2025 (RNS Number: 2759A), the Fundraising Shares (as defined in that announcement) have today been admitted to listing on the equity shares (transition) category of the Official List of the Financial Conduct Authority ("ES(T)C Listing"; "FCA") and to trading on the main market for listed securities of London Stock Exchange plc ("Main Market"; "LSE"). Following admission, the notification of transactions forms in respect of participations in Fundraising Shares and Fundraising Warrants (as also defined in that announcement) by Professor Ronjon Nag, Richard Edwards and Sarah Davy are shown below.

 

Conversion of all outstanding CLNs and issue of CLN Shares and Fee Shares

 

Further to the Company's announcement on 17 October 2024 (RNS Number: 6526I), the remaining convertible loan noteholders have converted their outstanding convertible loan notes ("CLNs") into 123,000,000 new ordinary shares of nominal value £0.00001 each in the capital of the Company (the "CLN Shares"; "Ordinary Shares"). Following the issuance of the CLN Shares, there are no CLNs outstanding.

 

In addition, the Company has issued the remaining fee shares as outlined in the Company's announcement on 29 January 2025 (RNS Number: 1581V). A total of 63,492,063 new ordinary shares (the "Fee Shares") have been issued to settle outstanding fees.

 

Applications have been made to the FCA and the LSE for admission of the CLN Shares and the Fee Shares (together, the "New Ordinary Shares") and it is expected that 186,492,063 New Ordinary Shares will be admitted to an ES(T)C Listing and to trading on the Main Market of the LSE at or around 8.00 a.m. on 11 April 2025.

 

Following admission, the Company will have 3,121,102,336 Ordinary Shares in issue, none of which are held in treasury. Therefore, the total number of voting rights in the Company shall be 3,121,102,336.

 

The above figure of 3,121,102,336 may be used by shareholders of the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

 

Company:

capAI plc hello@capaiplc.com

 

Broker Enquiries:

Peterhouse Capital Limited Tel: +44 (0) 207 469 0930

 

 

The information set out below is provided in accordance with the requirements of Article 19(3) of Regulation 2014/596/EU, which is part of the domestic law of the United Kingdom of Great Britain and Northern Ireland pursuant to the Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310). 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Professor Ronjon Nag

2. Richard Edwards

3. Sarah Davy

2

Reason for notification

a)

Position/status

1. Executive Director; PDMR

2. Executive Director; PDMR 

3. Non-Executive Director; PDMR

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

capAI plc

b)

LEI

213800IVPZ932NP24O44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of nominal value £0.00001 each

ISIN: GB00BMWC6Q55

b)

Nature of the transaction

Issue of new ordinary shares (Fundraising Shares) pursuant to the Company's announcement on 12 March 2025 (RNS Number: 2759A)

c)

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

1. £50,000

2. £50,000

3. £12,500

1. 125,000,000

2. 125,000,000

3. 31,250,000

d)

Aggregated information

- Aggregated volume

- Price

 

281,250,000

£112,500

 

e)

Date of the transaction

7 April 2025

f)

Place of the transaction

Outside of a trading venue

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Professor Ronjon Nag

2. Richard Edwards

3. Sarah Davy

2

Reason for notification

a)

Position/status

1. Executive Director; PDMR

2. Executive Director; PDMR 

3. Non-Executive Director; PDMR

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

capAI plc

b)

LEI

213800IVPZ932NP24O44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Warrants over ordinary shares of nominal value £0.00001 each

ISIN: GB00BMWC6Q55

b)

Nature of the transaction

Issue of warrants (Fundraising Warrants) over ordinary shares with an exercise price of £0.0008 pursuant to the Company's announcement on 12 March 2025 (RNS Number: 2759A)

c)

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

1. £Nil

2. £Nil

3. £Nil

1. 125,000,000

2. 125,000,000

3. 31,250,000

d)

Aggregated information

- Aggregated volume

- Price

 

281,250,000

£Nil

 

e)

Date of the transaction

7 April 2025

f)

Place of the transaction

Outside of a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGZGGDLNGGKZG
12
Date   Source Headline
9th Jun 20267:00 amRNScapMedia Platform Portfolio Update and Webinar
7th May 20267:00 amRNSExercise of Warrants
5th May 202611:31 amRNSHolding(s) in Company
28th Apr 20262:15 pmRNSHolding(s) in Company
21st Apr 20264:19 pmRNSResult of AGM
21st Apr 20267:00 amRNSAGM Trading & Strategic Update
27th Mar 20265:08 pmRNSNotice of AGM
27th Feb 202612:28 pmRNSTotal Voting Rights
10th Feb 20267:00 amRNSCommercial and Strategy Update, Fundraising
30th Jan 20261:25 pmRNSFinal Results
17th Dec 20259:21 amRNSBoard and Committee Changes
15th Dec 202510:08 amRNSHolding(s) in Company
18th Nov 20257:00 amRNSSoft Launch of Author42
17th Nov 202512:34 pmRNSHolding(s) in Company
17th Nov 20257:00 amRNSHolding(s) in Company
13th Nov 20257:00 amRNSHolding(s) in Company
5th Nov 20257:00 amRNSCommencement of Trading on OTCQB Venture Market
4th Nov 20253:06 pmRNSExercise of Warrants, TVR and Other Updates
15th Oct 20257:00 amRNSDelivery of Completion Notice for Creator42
14th Oct 20257:00 amRNSMove to SETS Trading Platform
8th Oct 20253:54 pmRNSDirector/PDMR and PCA Shareholdings
7th Oct 20257:00 amRNSIncorporation of capMedical Inc and Other Updates
6th Oct 20255:10 pmRNSResults of GM, Share Consolidation and TVR
17th Sep 20257:00 amRNSNotice of GM
16th Sep 20251:40 pmRNSHolding(s) in Company
5th Sep 20257:00 amRNScapMedia Inc Hires AI Innovator
4th Sep 20256:01 pmRNSExercise of Warrants
2nd Sep 20257:30 amRNSLicence and Option Agreement for Game42
29th Aug 20258:25 amRNSLicence and Option Agreement for Creator42
22nd Aug 202510:40 amRNS-RAuthor42 Beta Deployment and R42 Demo Day
20th Aug 20258:37 amRNSHolding(s) in Company
20th Aug 20258:14 amRNSHolding(s) in Company
20th Aug 20258:13 amRNSHolding(s) in Company
5th Aug 20258:38 amRNSExecution of Heads of Terms for Movie42
4th Aug 202510:28 amRNSExecution of Heads of Terms for Game42
31st Jul 202512:49 pmRNSR42 Institute Final Demo Day In Assoc. with capAI
25th Jul 20257:18 amRNSLicence and Option Agreement for Author42 Platform
22nd Jul 20257:00 amRNS-RcapMedia Inc US Business Registration Completed
10th Jul 20257:52 amRNSIncorporation of capMedia & US Operational Plans
7th Jul 20254:07 pmRNSwww.author42.com Goes Live and Beta Waitlist Opens
7th Jul 202510:06 amRNSExecution of Heads of Terms and Launch of capMedia
30th Jun 20253:11 pmRNSTotal Voting Rights
30th Jun 20252:18 pmRNSHalf-year Report
9th Jun 20252:00 pmRNSHolding(s) in Company
9th Jun 20259:00 amRNSIssue of Equivalent Shares and PDMR Notification
2nd Jun 20252:24 pmRNSHolding(s) in Company
2nd Jun 202510:44 amRNS-RStockBox Interview
29th May 20257:00 amRNSResults of General Meeting and other updates
27th May 20259:08 amRNSStrategic Alliance with R42
2nd May 202512:30 pmRNSExercise of Warrants, Circular and Notice of GM
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.